Moreover, in SSc-ILD cases with active disease and cases naïve to immunosuppressive therapy (8/23), only ICAM1 + EVs levels were found to be remarkably elevated [9.9 (0.6–359.0) vs. 1.25 (0–11.9), p < 0.001]. Here, ICAM1 is linked to interstitial lung disease.